Manchester Metropolitan University logo
e-space
Manchester Metropolitan University's Research Repository

    Items where Author is "Aballéa, Samuel"

    Up a level
    Export as [feed] Atom [feed] RSS
    Group by: Item Type | No Grouping
    Jump to: Article
    Number of items: 2.

    Article

    Kragh, Nana Tytula, Anna Pochopien, Michał Aballéa, Samuel Toumi, Mondher Hakimi, Zalmai Nazir, Jameel et al.
    Kragh, Nana, Tytula, Anna, Pochopien, Michał, Aballéa, Samuel, Toumi, Mondher, Hakimi, Zalmai, Nazir, Jameel, Bystrická, Linda and Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953
    (2023) Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK. European Journal of Haematology, 110 (3). pp. 262-270. ISSN 0902-4441

    Mancuso, Maria Elisa ORCID logoORCID: https://orcid.org/0000-0002-7113-4028 Castaman, Giancarlo ORCID logoORCID: https://orcid.org/0000-0003-4973-1317 Pochopien, Michal Aballéa, Samuel Drzewiecka, Aleksandra ORCID logoORCID: https://orcid.org/0000-0003-3396-8571 Hakimi, Zalmai ORCID logoORCID: https://orcid.org/0000-0001-5835-8599 Nazir, Jameel et al.
    Mancuso, Maria Elisa ORCID logoORCID: https://orcid.org/0000-0002-7113-4028, Castaman, Giancarlo ORCID logoORCID: https://orcid.org/0000-0003-4973-1317, Pochopien, Michal, Aballéa, Samuel, Drzewiecka, Aleksandra ORCID logoORCID: https://orcid.org/0000-0003-3396-8571, Hakimi, Zalmai ORCID logoORCID: https://orcid.org/0000-0001-5835-8599, Nazir, Jameel and Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953
    (2022) Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe. Journal of Medical Economics, 25 (1). pp. 1068-1075. ISSN 1369-6998

    This list was generated on Sat Apr 27 06:01:20 2024 BST.